YU35033B - Process for preparing aminopurine derivatives - Google Patents

Process for preparing aminopurine derivatives

Info

Publication number
YU35033B
YU35033B YU2806/70A YU280670A YU35033B YU 35033 B YU35033 B YU 35033B YU 2806/70 A YU2806/70 A YU 2806/70A YU 280670 A YU280670 A YU 280670A YU 35033 B YU35033 B YU 35033B
Authority
YU
Yugoslavia
Prior art keywords
preparing
aminopurine derivatives
aminopurine
derivatives
preparing aminopurine
Prior art date
Application number
YU2806/70A
Other languages
English (en)
Other versions
YU280670A (en
Inventor
Elion B Gertrude
B Gertrude Elion
Strelitz A Robert
A Robert Strelitz
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of YU280670A publication Critical patent/YU280670A/xx
Publication of YU35033B publication Critical patent/YU35033B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
YU2806/70A 1969-11-17 1970-11-16 Process for preparing aminopurine derivatives YU35033B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
YU280670A YU280670A (en) 1979-12-31
YU35033B true YU35033B (en) 1980-06-30

Family

ID=25369972

Family Applications (2)

Application Number Title Priority Date Filing Date
YU2806/70A YU35033B (en) 1969-11-17 1970-11-16 Process for preparing aminopurine derivatives
YU2019/78A YU35034B (en) 1969-11-17 1978-08-24 Process for preparing aminopurine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU2019/78A YU35034B (en) 1969-11-17 1978-08-24 Process for preparing aminopurine derivatives

Country Status (26)

Country Link
US (1) US3666856A (fr)
JP (1) JPS5429520B1 (fr)
AT (1) AT309696B (fr)
BE (1) BE759011A (fr)
BR (1) BR6915136D0 (fr)
CA (1) CA967564A (fr)
CH (2) CH555344A (fr)
CS (1) CS181701B2 (fr)
DE (1) DE2056327C2 (fr)
DK (1) DK128117B (fr)
ES (2) ES385590A1 (fr)
FI (1) FI54315C (fr)
FR (1) FR2073364B1 (fr)
GB (2) GB1338906A (fr)
HU (1) HU163812B (fr)
IE (1) IE34737B1 (fr)
IL (1) IL35658A (fr)
LU (1) LU62071A1 (fr)
MC (1) MC869A1 (fr)
NL (1) NL171589C (fr)
NO (1) NO128156B (fr)
PL (1) PL81167B1 (fr)
SE (1) SE385374B (fr)
YU (2) YU35033B (fr)
ZA (1) ZA707722B (fr)
ZM (1) ZM12970A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
WO1989008658A1 (fr) * 1988-03-16 1989-09-21 Scripps Clinic And Research Foundation Derives d'adenine substitues utiles en tant qu'agents therapeutiques
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
WO1999057120A1 (fr) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Nouvelle hypoxanthine 9-substituee apparentee a la serotonine
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001271908A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
IE34737B1 (en) 1975-08-06
CS181701B2 (en) 1978-03-31
DE2056327C2 (de) 1984-10-11
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
SE385374B (sv) 1976-06-28
FI54315B (fi) 1978-07-31
IL35658A0 (en) 1971-01-28
ZA707722B (en) 1972-06-28
NL171589B (nl) 1982-11-16
CH555344A (de) 1974-10-31
BR6915136D0 (pt) 1973-04-19
LU62071A1 (fr) 1971-08-12
JPS5429520B1 (fr) 1979-09-25
ES385590A1 (es) 1973-10-01
US3666856A (en) 1972-05-30
YU35034B (en) 1980-06-30
NO128156B (fr) 1973-10-08
FI54315C (fi) 1978-11-10
DE2056327A1 (de) 1971-06-03
YU280670A (en) 1979-12-31
MC869A1 (fr) 1971-09-28
FR2073364B1 (fr) 1974-03-22
HU163812B (fr) 1973-10-27
GB1338906A (en) 1973-11-28
IE34737L (en) 1971-05-17
AT309696B (de) 1973-08-27
IL35658A (en) 1974-10-22
CH555833A (de) 1974-11-15
DK128117B (da) 1974-03-04
YU201978A (en) 1979-12-31
NL171589C (nl) 1983-04-18
FR2073364A1 (fr) 1971-10-01
ZM12970A1 (en) 1972-07-21
CA967564A (en) 1975-05-13
BE759011A (fr) 1971-05-17
NL7016766A (fr) 1971-05-19
PL81167B1 (fr) 1975-08-30

Similar Documents

Publication Publication Date Title
YU294570A (en) Process for preparing delta-alkylamino-propiophenones
YU3277A (en) Process for preparing quinazoline derivatives
YU280670A (en) Process for preparing aminopurine derivatives
YU35009B (en) Process for preparing morpholine derivatives
YU137978A (en) Process for preparing naphthylalkylamines
YU231769A (en) Process for preparing pyrindol derivatives
YU303970A (en) Process for preparing novel evomonoside derivatives
YU34678B (en) Process for preparing 9-azolyl-fluorne-9-carboxylic acid derivatives
YU33975B (en) Process for preparing bufatrienolide-rhamnoside-acylates
YU309570A (en) Process for preparing digitoxigenin-delta-l-thevetoside derivatives
YU34998B (en) Process for preparing 3-amino-2-pyrazoline derivatives
YU34399B (en) Process for preparing thiamphenicol-glycinate acetylcysteinate
YU33967B (en) Process for preparing lumilysergic acid derivatives
YU220170A (en) Process for preparing novel p-amino-alyklbenzene-sulfonamide derivatives
YU34881B (en) Process for preparing benzodiazepine derivatives
YU188170A (en) Process for preparing 5-hydroxy-or 6-hydroxy-isoquinuclidines
YU144670A (en) Process for preparing substituted shloroacylanilides
YU35350B (en) Process for preparing bis-formamide derivatives
YU201270A (en) Process for preparing phenyl-3-tert.-butyl-5-oxadiazolone-2
YU34788B (en) Process for preparing 3-chloro-4-n-and-iso-propoxy-ureas
YU207170A (en) Process for preparing 5-halo-salicylic acid derivatives
YU34046B (en) Process for preparing substituted 5-nitrofuryl-pyrazole derivatives
CA823204A (en) Process for preparing 3-cyanomethylene-pregnene derivatives
YU35336B (en) Process for obtaining bis-alkanolamine derivatives
YU167369A (en) Process for preparing 9delta-fluoro-16-methylene-prednisolone-21-acetate